|
Volumn 318, Issue 2, 2017, Pages 197-198
|
Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
CANCER THERAPY;
CONTROLLED STUDY;
E-MAIL;
FEMALE;
FOLLOW UP;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
OVERALL SURVIVAL;
PATIENT MONITORING;
PATIENT-REPORTED OUTCOME;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SELF REPORT;
SOLID MALIGNANT NEOPLASM;
SYMPTOM;
COMPARATIVE STUDY;
COMPLICATION;
MIDDLE AGED;
MORTALITY;
NEOPLASM;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SURVIVAL ANALYSIS;
SYMPTOM ASSESSMENT;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASMS;
PATIENT REPORTED OUTCOME MEASURES;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SURVIVAL ANALYSIS;
SYMPTOM ASSESSMENT;
|
EID: 85020425017
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2017.7156 Document Type: Letter |
Times cited : (1508)
|
References (4)
|